Diammonium sulfite monohydrate (Ammonium sulfite monohydrate) has a wide use of applications, such as hair straightening or waving agents, as an ingredient in carmel food coloring, as well as an reducing agent in photography. Other applications include lubricants for cold metal working and blast furnace linings. It is considered safe as used in cosmetic formulations.

Diammonium sulfite monohydrate (Ammonium sulfite monohydrate) has a wide use of applications, such as hair straightening or waving agents, as an ingredient in carmel food coloring, as well as an reducing agent in photography. Other applications include lubricants for cold metal working and blast furnace linings. It is considered safe as used in cosmetic formulations.

Diammonium sulfite monohydrate (Ammonium sulfite monohydrate) has a wide use of applications, such as hair straightening or waving agents, as an ingredient in carmel food coloring, as well as an reducing agent in photography. Other applications include lubricants for cold metal working and blast furnace linings. It is considered safe as used in cosmetic formulations.

Diammonium sulfite monohydrate (Ammonium sulfite monohydrate) has a wide use of applications, such as hair straightening or waving agents, as an ingredient in carmel food coloring, as well as an reducing agent in photography. Other applications include lubricants for cold metal working and blast furnace linings. It is considered safe as used in cosmetic formulations.

Diammonium sulfite monohydrate (Ammonium sulfite monohydrate) has a wide use of applications, such as hair straightening or waving agents, as an ingredient in carmel food coloring, as well as an reducing agent in photography. Other applications include lubricants for cold metal working and blast furnace linings. It is considered safe as used in cosmetic formulations.

Diiodotyrosine (DIT) is a regulatory ligand for thyroid peroxidase, enzyme, which is involved in the production of thyroxine (T4) and triiodothyronine (T3), the thyroid hormones. Diiodotyrosine was proposed to be a new marker of leukocyte phagocytic activity in sepsis and severe infections.

Benidipine is an orally triple L-, T-, and N-type calcium channel blocker for the treatment of hypertension and angina pectoris synthesized and developed by Kyowa Hakko Kogyo Co., Ltd. Benidipine, approved in Japan in November 1991, has become one of the three best selling CCBs and is highly useful as a potent, long-lasting antihypertensive and antianginal agent.

Beta-Hydroxyisovaleric acid (also known as 3-hydroxyisovaleric acid or 3HIA) is a normal human metabolite excreted in the urine. It is a byproduct of the leucine degradation pathway. Beta-Hydroxyisovaleric acid serves as a sensitive indicator of marginal biotin deficiency in humans. The variability of the proportion of leucine catabolites excreted as 3HIA suggests substantial population heterogeneity in the metabolic capacity of the 3HIA-carnitine detoxification pathway. In addition, was shown that in type II diabetic patients the catabolism of leucine was accelerated even in the absence of ketosis and that the urinary beta-hydroxyisovaleric acid concentration was a useful marker of short-term metabolic control in these patients.

Bifendate is a synthetic intermediate of Schisandrin C and also an anti-HBV drug used in Chinese medicine for the treatment of chronic hepatitis B. Following the intake of Bifendate in rats, the drug was observed to improve liver function by increasing the detoxification process, reducing pathological lesions, and accelerating hepatocyte regeneration. Bifendate can also function as a membrane-stabilizing agent to protect the cell from damage. After treatment with Bifendate, the protein metabolic processes of hepatitis patients were improved, with increased serum albumin levels and decreased globulin levels. Bifendate is a potent inducer of cytochrome proteins (CYPs) and can result in clinically significant interactions. It has been proposed that the increased detoxification capability of Bifendate originates from an increase in the level of P450. Bifendate may function as a protecting agent to prevent drug-induced liver dysfunction by increasing the activity of CYP450.

Bifendate is a synthetic intermediate of Schisandrin C and also an anti-HBV drug used in Chinese medicine for the treatment of chronic hepatitis B. Following the intake of Bifendate in rats, the drug was observed to improve liver function by increasing the detoxification process, reducing pathological lesions, and accelerating hepatocyte regeneration. Bifendate can also function as a membrane-stabilizing agent to protect the cell from damage. After treatment with Bifendate, the protein metabolic processes of hepatitis patients were improved, with increased serum albumin levels and decreased globulin levels. Bifendate is a potent inducer of cytochrome proteins (CYPs) and can result in clinically significant interactions. It has been proposed that the increased detoxification capability of Bifendate originates from an increase in the level of P450. Bifendate may function as a protecting agent to prevent drug-induced liver dysfunction by increasing the activity of CYP450.